Tag: clinical trial transparency

Using Journal Policies & Preprints to Support Publications, HTA and Market Access Using Journal Policies & Preprints to Support Publications, HTA and Market Access The integration of real-world evidence (RWE) into clinical development and the dissemination of research findings play a pivotal role in the regulatory landscape, particularly concerning Health Technology Assessment (HTA) and market…

Read More “Using Journal Policies & Preprints to Support Publications, HTA and Market Access” »

Future Trends: AI, Real-World Data and Evolving Rules for Journal Policies & Preprints Future Trends: AI, Real-World Data and Evolving Rules for Journal Policies & Preprints In the evolving landscape of clinical research, understanding the intersection of artificial intelligence (AI), real-world data (RWD), and journal publication policies is paramount for clinical operations, regulatory affairs, and…

Read More “Future Trends: AI, Real-World Data and Evolving Rules for Journal Policies & Preprints” »

Vendor and Partner Oversight Considerations for Journal Policies & Preprints Vendor and Partner Oversight Considerations for Journal Policies & Preprints Introduction to Regulatory Publishing in Clinical Trials In the contemporary landscape of clinical research, ensuring transparency and compliance is crucial. Regulatory publishing has become an essential facet of clinical trials, particularly related to the dissemination…

Read More “Vendor and Partner Oversight Considerations for Journal Policies & Preprints” »

Training Clinical, Regulatory and Medical Teams on Journal Policies & Preprints Training Clinical, Regulatory and Medical Teams on Journal Policies & Preprints Introduction to Journal Policies and Preprints in Clinical Trials The landscape of clinical trials is continually evolving, requiring clinical, regulatory, and medical affairs professionals to stay informed about the latest in journal policies…

Read More “Training Clinical, Regulatory and Medical Teams on Journal Policies & Preprints” »

Case Studies: Journal Policies & Preprints That Strengthened Public and Regulator Trust In the landscape of clinical research trials, trust plays a pivotal role in ensuring the integrity of the process and the reliability of outcomes. This tutorial guide aims to present a series of case studies focusing on journal policies and preprints, demonstrating their…

Read More “Case Studies: Journal Policies & Preprints That Strengthened Public and Regulator Trust” »

Integrating Journal Policies & Preprints With Data Privacy, GDPR and HIPAA Requirements The integration of journal policies and preprints with data privacy frameworks, particularly the General Data Protection Regulation (GDPR) and the Health Insurance Portability and Accountability Act (HIPAA), presents intricate challenges and opportunities in the realm of translational clinical research. This guide provides a…

Read More “Integrating Journal Policies & Preprints With Data Privacy, GDPR and HIPAA Requirements” »

Inspection and Audit Readiness: Documenting Journal Policies & Preprints for Regulators Inspection and Audit Readiness: Documenting Journal Policies & Preprints for Regulators Clinical trials represent a critical pathway for the development of innovative therapies. However, with the rigorous regulatory frameworks established by organizations such as the FDA, EMA, and MHRA, it is essential for clinical…

Read More “Inspection and Audit Readiness: Documenting Journal Policies & Preprints for Regulators” »

KRIs, KPIs and Dashboards to Monitor Journal Policies & Preprints Across Portfolios KRIs, KPIs and Dashboards to Monitor Journal Policies & Preprints Across Portfolios In the ever-evolving landscape of clinical research, the need for transparency and compliance has never been more crucial. With the increasing complexity of clinical research trials and the imperative nature of…

Read More “KRIs, KPIs and Dashboards to Monitor Journal Policies & Preprints Across Portfolios” »

Journal Policies & Preprints Playbook for High-Profile and Late-Phase Trials Journal Policies & Preprints Playbook for High-Profile and Late-Phase Trials In the rapidly evolving landscape of clinical research, transparency and timely dissemination of findings have become paramount. This step-by-step tutorial aims to provide clinical operations, regulatory affairs, and medical affairs professionals in the US, UK,…

Read More “Journal Policies & Preprints Playbook for High-Profile and Late-Phase Trials” »

Digital Tools and Automation to Streamline Journal Policies & Preprints In today’s clinical research landscape, transparency and efficient communication of study results have become paramount. The integration of digital tools and automation in managing journal policies and preprints can significantly enhance compliance and accessibility of findings. This article outlines a comprehensive step-by-step guide on how…

Read More “Digital Tools and Automation to Streamline Journal Policies & Preprints” »